Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allogene Therapeutics, Inc. | SVP, Finance | Common Stock | 88.9K | $282K | $3.17 | Aug 10, 2023 | Direct |
Allogene Therapeutics, Inc. | SVP, Finance | Stock Option (Right to Buy) | 39.2K | Aug 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | Aug 10, 2023 | 2 | $0 | 4 | Aug 14, 2023 | SVP, Finance |
ALLO | Allogene Therapeutics, Inc. | Aug 10, 2023 | 0 | $0 | 3 | Aug 14, 2023 | SVP, Finance |